SHFH - Scientist Home Future Health Limited
A high-level overview of Scientist Home Future Health Limited (SHFH) stock. View (SHFH) real-time stock price, chart, news, ...
Model output · Signal date 2026-11-04
Scientist Home Future Health Ltd (SHFH) Stock Forecast Nov. 4, 2026
Analysis updated on Nov. 4, 2026 (UTC) · Alpha · vs marketSwitch to Total · OTC
Rating · 90D
Unlock rating and forecasts
90-day forecast
Sign up free to reveal
30-day forecast
Alpha
Rank in coverage
of 5150 stocks scored
Rank correlation · 90D
-50.0%
Spearman, 64 dates
Market Cap
$25M
small-cap · #13 of 16 peers
Summary
Scientist Home Future Health Ltd (SHFH) stock forecast summary
Our AI scores Scientist Home Future Health Ltd every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Scientist Home Future Health Ltd is a small-cap company with a market capitalization of $25M. It ranks number 13 by market capitalization among the 16 Perfumes, Cosmetics & Other Toilet Preparations issuers in our coverage with a current forecast.
For SHFH, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -50.0%, measured on 64 forecast dates between 2026-05-11 and 2026-08-06 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -58.0%, measured on 106 forecast dates between 2026-05-11 and 2026-10-05. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, SHFH included.
Price
SHFH price chart and AI forecast
Cross-section · 2026-11-06
How SHFH ranks among 5150 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Fundamentals · 2026-09-30
Scientist Home Future Health Ltd (SHFH) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Perfumes, Cosmetics & Other Toilet Preparations peers listed below that report each metric.
Valuation & Market
| Metric | SHFH | Rank |
|---|---|---|
| Market Cap | $25M | 13/16 |
| EPS | $-0.01 | – |
| Revenue/Share | $0.02 | – |
Profitability & Margins
| Metric | SHFH | Rank |
|---|---|---|
| ROA | -56.7% | 12/14 |
| ROIC | -187.4% | 13/13 |
| Gross Margin | 42.2% | 11/14 |
| Operating Margin | -60.1% | 14/15 |
| Net Margin | -60.1% | 13/14 |
| EBT Margin | -60.1% | 14/15 |
| Tax Rate | -0.5% | – |
Financial Health
| Metric | SHFH | Rank |
|---|---|---|
| Current Ratio | 0.53x | 14/15 |
| Quick Ratio | 0.23x | 15/15 |
| Working Capital | -$200K | 9/15 |
Cash Flow
| Metric | SHFH | Rank |
|---|---|---|
| Operating Cash Flow | -$270K | 12/15 |
Operational Efficiency
| Metric | SHFH | Rank |
|---|---|---|
| Asset Turnover | 0.94x | 7/13 |
| Inventory Turnover | -0.5x | 14/14 |
| Fixed Assets Turnover | 9.3x | 6/13 |
| Days Inventory | -719 days | 14/14 |
| Payables Period | -151 days | 13/13 |
Income Statement
| Metric | SHFH | Rank |
|---|---|---|
| Total Revenue | $570K | 13/13 |
| Operating Income | -$340K | 9/15 |
| Net Income | -$340K | 8/14 |
| SG&A Expense | $590K | 11/12 |
| Cost of Goods Sold | -$70K | 14/14 |
Dividend & Shareholder Information
| Metric | SHFH | Rank |
|---|---|---|
| Shares Outstanding | 24M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $230K | |
| Cash & Short-term Investments | $10K | |
| Inventory | $130K | |
| Total Liabilities | $690K | |
| Short-term Debt | $400K |
Quarterly Financial Reports
SHFH quarterly financials and insider trading
Industry Peers · Perfumes, Cosmetics & Other Toilet Preparations
Scientist Home Future Health Ltd (SHFH) industry peers
Companies classified under the same SEC industry code as Scientist Home Future Health Ltd (Perfumes, Cosmetics & Other Toilet Preparations): 16 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| SHFH Scientist Home Future Health Ltd | $25M | |
| CL Colgate Palmolive Co | $76.76B | |
| HLN Haleon Plc | $40.32B | |
| EL Estee Lauder Companies Inc | $39.82B | |
| KVUE Kenvue Inc. | $37.11B | |
| ELF E.L.F. Beauty, Inc. | $6.85B | |
| IPAR Interparfums Inc | $4.34B | |
| COTY Coty Inc. | $3.57B | |
| EPC Edgewell Personal Care Co | $1.29B | |
| ODD Oddity Tech Ltd | $931M | |
| SLSN Solesence, Inc. | $61M | |
| AXIL Axil Brands, Inc. | $35M | |
| UG United Guardian Inc | $31M | |
| KARX Karbon-X Corp. | $16M | |
| CABR Caring Brands, Inc. | $8M | |
| YCBD Cbdmd, Inc. | $4M |
Where SHFH sits on the market map
Industrial Applications and Services · Perfumes, Cosmetics & Other Toilet Preparations
News
Scientist Home Future Health Ltd (SHFH) stock news
Scientist Home Future Health Trial Demonstrates Significant Reduction in Eczema Symptoms using Evidence-based Nutritional Therapy
HONG KONG, Sept. 10, 2026 (GLOBE NEWSWIRE)-- Scientist Home Future Health LTD (OTCID: SHFH) (Scientist home or 'The Company') is pleased to announce Researchers at Scientist Home have announced ...
Scientist Home Future Health Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
Scientist Home Future Health Limited reported earnings results for the third quarter and nine months ended September 30, 2026. For the third quarter, the company reported sales was USD 0.209623 ...
FAQ
Scientist Home Future Health Ltd (SHFH) stock forecast FAQ
What is the Scientist Home Future Health Ltd (SHFH) stock forecast?
Our AI scores Scientist Home Future Health Ltd every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
How accurate are Scientist Home Future Health Ltd stock predictions?
For SHFH, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -50.0%, measured on 64 forecast dates between 2026-05-11 and 2026-08-06 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -58.0%, measured on 106 forecast dates between 2026-05-11 and 2026-10-05. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Scientist Home Future Health Ltd forecasts updated?
Scientist Home Future Health Ltd forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 4, 2026.
Which companies are Scientist Home Future Health Ltd's industry peers?
16 issuers in our coverage, SHFH included, share the SEC industry code Perfumes, Cosmetics & Other Toilet Preparations. The largest are: Colgate Palmolive Co (CL), Haleon Plc (HLN), Estee Lauder Companies Inc (EL), Kenvue Inc. (KVUE), E.L.F. Beauty, Inc. (ELF), Interparfums Inc (IPAR).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.